Neuroinflammation occuring after traumatic brain injury (TBI) is a complex
phenomenon comprising distinct cellular and molecular events involving the
injured as well as the healthy cerebral tissue. Although immunoactivation o
nly represents a one of the many cascades initiated in the pathophysiology
of TBI, the exact function of each mediator, activated cell types or pathop
hysiological mechanism, needs to be further elucidated. It is widely accept
ed that inflammatory events display dual and opposing roles promoting, on t
he one hand, the repair of the injured tissue and, on the other hand, causi
ng additional brain damage mediated by the numerous neurotoxic substances r
eleased. Most of the data supporting these hypotheses derive from experimen
tal work based on both animal models and cultured neuronal cells. More rece
ntly, evidence has been provided that a complete elimination of selected in
flammatory mediators is rather detrimental as shown by the attenuation of n
eurological recovery. However, there are conflicting results reported on th
is issue which strongly depend on the experimental setting used. The histor
y of immunoactivation in neurotrauma is the subject of this review article,
giving particular emphasis to the comparison of clinical versus experiment
al studies performed over the last 10 years. These results also are evaluat
ed with respect to other neuropathologies, which are years ahead as compare
d to the research in TBI. The possible reciprocal influence of peripheral a
nd intrathecal activation of the immune system will also be discussed. To c
onclude, the future directions of research in the field of neurotrauma is c
onsidered.